![John Thompson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 30/06/2026
John Craig Thompson is currently Chief Executive Officer & Director at Cerevance, Inc. since 2022 and Independent Non-Executive Director at NervGen Pharma Corp.
since 2022.
Former roles include President, Chief Executive Officer & Director at Anthera Pharmaceuticals, Inc. from 2016 to 2018; President & Chief Executive Officer at Neurana Pharmaceuticals, Inc.; Independent Director at Esperion Therapeutics, Inc. from 2025 to 2026; Vice President-Marketing at Pfizer Inc. from 2003 to 2010; Chief Operating Officer at Tetraphase Pharmaceuticals, Inc. from 2014 to 2015; and Chief Commercial Officer at Trius Therapeutics, Inc. Education includes an MBA from the University of Notre Dame and an undergraduate degree from McMaster University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NERVGEN PHARMA CORP. -.--% | 16/05/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NERVGEN PHARMA CORP. | Director/Miembro de la Junta | 13/04/2022 |
Cerevance, Inc.
 Cerevance, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Director Ejecutivo | 01/04/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Director/Miembro de la Junta | 13/07/2026 |
| ANTHERA PHARMACEUTICALS, INC. | Director Ejecutivo | 30/06/2018 |
| TETRAPHASE PHARMACEUTICALS, INC. | Director de Operaciones | 31/12/2015 |
| PFIZER INC. | Ventas & Marketing | 01/01/2010 |
Neurana Pharmaceuticals, Inc.
 Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Anthera Pharmaceuticals, Inc.
 Anthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of medicines for patients with unmet medical needs | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
McMaster University
 McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Health Technology |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Health Technology |
NervGen Pharma Corp.
 NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
